MAPT and Alzheimer disease: It is well established that Fyn can play a dual role in both the Aβ and tau pathologies observed in AD [21], exacerbating Aβ neurotoxicity through cellular prion protein (PrPC) and interacting directly with tau [22] by phosphorylating it at Tyr18 [23].